Breast Cancer, Version 3.2018 Featured Updates to the NCCN Guidelines

被引：149

作者：

Goetz, Matthew P. ^{[1
]}

Gradishar, William J. ^{[2
]}

Anderson, Benjamin O. ^{[3
]}

Abraham, Jame ^{[4
,5
]}

Aft, Rebecca ^{[6
,7
]}

Allison, Kimberly H. ^{[8
]}

Blair, Sarah L. ^{[9
]}

Burstein, Harold J. ^{[10
]}

Dang, Chau ^{[11
]}

Elias, Anthony D. ^{[12
]}

Farrar, William B. ^{[13
]}

Giordano, Sharon H. ^{[14
]}

Goldstein, Lori J. ^{[15
]}

Isakoff, Steven J. ^{[16
]}

Lyons, Janice ^{[4
,5
]}

Marcom, P. Kelly ^{[17
]}

Mayer, Ingrid A. ^{[18
]}

Moran, Meena S. ^{[19
]}

Mortimer, Joanne ^{[20
]}

O'Regan, Ruth M. ^{[21
]}

Patel, Sameer A. ^{[15
]}

Pierce, Lori J. ^{[22
]}

Reed, Elizabeth C. ^{[23
]}

Rugo, Hope S. ^{[24
]}

Sitapati, Amy ^{[9
]}

Smith, Karen Lisa ^{[25
]}

Smith, Mary Lou ^{[26
]}

Soliman, Hatem ^{[27
]}

Telli, Melinda L. ^{[8
]}

Ward, John H. ^{[28
]}

Young, Jessica S. ^{[29
]}

Shead, Dorothy A. ^{[30
]}

Kumar, Rashmi ^{[30
]}

机构：

[1] Mayo Clin, Ctr Canc, Rochester, MN 55905 USA

[2] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL 60208 USA

[3] Univ Washington, Seattle Canc Care Alliance, Seattle, WA 98195 USA

[4] Univ Hosp Seidman Canc Ctr, Case Comprehens Canc Ctr, Cleveland, OH USA

[5] Cleveland Clin, Taussig Canc Inst, Cleveland, OH USA

[6] Barnes Jewish Hosp, Siteman Canc Ctr, St Louis, MO USA

[7] Washington Univ, Sch Med, St Louis, MO 63130 USA

[8] Stanford Canc Inst, Stanford, CA USA

[9] UC San Diego Moores Canc Ctr, La Jolla, CA USA

[10] Dana Farber Brigham & Womens Canc Ctr, Boston, MA USA

[11] Mem Sloan Kettering Canc Ctr, New York, NY USA

[12] Univ Colorado, Ctr Canc, Boulder, CO 80309 USA

[13] Ohio State Univ, Ctr Comprehens Canc, James Canc Hosp & Solove Res Inst, Columbus, OH 43210 USA

[14] Univ Texas MD Anderson Canc Ctr, Houston, TX USA

[15] Fox Chase Canc Ctr, Philadelphia, PA USA

[16] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA

[17] Duke Canc Inst, Durham, NC USA

[18] Vanderbilt Ingram Canc Ctr, Nashville, TN USA

[19] Yale Canc Ctr, Smilow Canc Hosp, New Haven, CT USA

[20] City Hope Natl Med Ctr, Duarte, CA USA

[21] Univ Wisconsin, Carbone Canc Ctr, Madison, WI 53706 USA

[22] Univ Michigan, Rogel Canc Ctr, Ann Arbor, MI 48109 USA

[23] Fred & Pamela Buffett Canc Ctr, Omaha, NE USA

[24] UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA

[25] Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA

[26] Res Advocacy Network, Pittsburgh, PA USA

[27] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[28] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA

[29] Roswell Pk Comprehens Canc Ctr, Buffalo, NY USA

[30] Natl Comprehens Canc Network, Plymouth Meeting, PA USA

来源：

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2019年 / 17卷 / 02期

关键词：

21-GENE RECURRENCE SCORE; 2-GENE EXPRESSION RATIO; DISTANT RECURRENCE; RECEPTOR; PREDICTION; TAMOXIFEN; INDEX; RISK; CHEMOTHERAPY; WOMEN;

D O I：

10.6004/jnccn.2019.0009

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

These NCCN Guidelines Insights highlight the updated recommendations for use of multigene assays to guide decisions on adjuvant systemic chemotherapy therapy for women with hormone receptor-positive, HER2-negative early-stage invasive breast cancer. This report summarizes these updates and discusses the rationale behind them.

引用

页码：119 / 126

页数：8

共 22 条

[1] Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial [J].

Albain, Kathy S. ;

Barlow, William E. ;

Shak, Steven ;

Hortobagyi, Gabriel N. ;

Livingston, Robert B. ;

Yeh, I-Tien ;

Ravdin, Peter ;

Bugarini, Roberto ;

Boehner, Frederick L. ;

Davidson, Nancy E. ;

Sledge, George W. ;

Winer, Eric P. ;

Hudis, Clifford ;

Ingle, James N. ;

Perez, Edith A. ;

Pritchard, Kathleen I. ;

Shepherd, Lois ;

Gralow, Julie R. ;

Yoshizawa, Carl ;

Allred, D. Craig ;

Osborne, C. Kent ;

Hayes, Daniel F. .

LANCET ONCOLOGY, 2010, 11 (01) :55-65

[2] Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer [J].

Berry, DA ;

Cirrincione, C ;

Henderson, IC ;

Citron, ML ;

Budman, DR ;

Goldstein, LJ ;

Martino, S ;

Perez, EA ;

Muss, HB ;

Norton, L ;

Hudis, C ;

Winer, EP .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (14) :1658-1667

[3] 70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer [J].

Cardoso, F. ;

van't Veer, L. J. ;

Bogaerts, J. ;

Slaets, L. ;

Viale, G. ;

Delaloge, S. ;

Pierga, J. -Y. ;

Brain, E. ;

Causeret, S. ;

DeLorenzi, M. ;

Glas, A. M. ;

Golfinopoulos, V. ;

Goulioti, T. ;

Knox, S. ;

Matos, E. ;

Meulemans, B. ;

Neijenhuis, P. A. ;

Nitz, U. ;

Passalacqua, R. ;

Ravdin, P. ;

Rubio, I. T. ;

Saghatchian, M. ;

Smilde, T. J. ;

Sotiriou, C. ;

Stork, L. ;

Straehle, C. ;

Thomas, G. ;

Thompson, A. M. ;

van der Hoeven, J. M. ;

Vuylsteke, P. ;

Bernards, R. ;

Tryfonidis, K. ;

Rutgers, E. ;

Piccart, M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (08) :717-729

[4] Comparison of PAM50 Risk of Recurrence Score With Oncotype DX and IHC4 for Predicting Risk of Distant Recurrence After Endocrine Therapy [J].

Dowsett, Mitch ;

Sestak, Ivana ;

Lopez-Knowles, Elena ;

Sidhu, Kalvinder ;

Dunbier, Anita K. ;

Cowens, J. Wayne ;

Ferree, Sean ;

Storhoff, James ;

Schaper, Carl ;

Cuzick, Jack .

JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (22) :2783-+

[5] Prediction of Risk of Distant Recurrence Using the 21-Gene Recurrence Score in Node-Negative and Node-Positive Postmenopausal Patients With Breast Cancer Treated With Anastrozole or Tamoxifen: A TransATAC Study [J].

Dowsett, Mitch ;

Cuzick, Jack ;

Wale, Christopher ;

Forbes, John ;

Mallon, Elizabeth A. ;

Salter, Janine ;

Quinn, Emma ;

Dunbier, Anita ;

Baum, Michael ;

Buzdar, Aman ;

Howell, Anthony ;

Bugarini, Roberto ;

Baehner, Frederick L. ;

Shak, Steven .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (11) :1829-1834

[6] A New Molecular Predictor of Distant Recurrence in ER-Positive, HER2-Negative Breast Cancer Adds Independent Information to Conventional Clinical Risk Factors [J].

Filipits, Martin ;

Rudas, Margaretha ;

Jakesz, Raimund ;

Dubsky, Peter ;

Fitzal, Florian ;

Singer, Christian F. ;

Dietze, Otto ;

Greil, Richard ;

Jelen, Andrea ;

Sevelda, Paul ;

Freibauer, Christa ;

Mueller, Volkmar ;

Jaenicke, Fritz ;

Schmidt, Marcus ;

Koelbl, Heinz ;

Rody, Achim ;

Kaufmann, Manfred ;

Schroth, Werner ;

Brauch, Hiltrud ;

Schwab, Matthias ;

Fritz, Peter ;

Weber, Karsten E. ;

Feder, Inke S. ;

Hennig, Guido ;

Kronenwett, Ralf ;

Gehrmann, Mathias ;

Gnant, Michael .

CLINICAL CANCER RESEARCH, 2011, 17 (18) :6012-6020

[7] A two-gene expression ratio of homeobox 13 and interleukin-17B receptor for prediction of recurrence and survival in women receiving adjuvant tamoxifen [J].

Goetz, MP ;

Suman, VJ ;

Ingle, JN ;

Nibbe, AM ;

Visscher, DW ;

Reynolds, CA ;

Lingle, WL ;

Erlander, M ;

Ma, XJ ;

Sgroi, DC ;

Perez, EA ;

Couch, FJ .

CLINICAL CANCER RESEARCH, 2006, 12 (07) :2080-2087

[8] HOXB13-to-IL17BR expression ratio is related with tumor aggressiveness and response to tamoxifen of recurrent breast cancer:: A retrospective study [J].

Jansen, Maurice P. H. M. ;

Sieuwerts, Anieta M. ;

Look, Maxime P. ;

Ritstier, Kirsten ;

Meijer-van Gelder, Marion E. ;

van Staveren, Iris L. ;

Klijn, Jan G. M. ;

Foekens, John A. ;

Berns, Els M. J. J. .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (06) :662-668

[9] PAM50 Risk of Recurrence Score Predicts 10-Year Distant Recurrence in a Comprehensive Danish Cohort of Postmenopausal Women Allocated to 5 Years of Endocrine Therapy for Hormone Receptor-Positive Early Breast Cancer [J].

Laenkholm, Anne-Vibeke ;

Jensen, Maj-Britt ;

Eriksen, Jens Ole ;

Rasmussen, Birgitte Bruun ;

Knoop, Ann S. ;

Buckingham, Wesley ;

Ferree, Sean ;

Schaper, Carl ;

Nielsen, Torsten O. ;

Haffner, Taryn ;

Kibol, Torben ;

Talman, Maj-Lis Moller ;

Jylling, Anne Marie Bak ;

Tabor, Tomasz Piotr ;

Ejlertsen, Bent .

JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (08) :735-+

[10] A five-gene molecular grade index and HOXB13:IL17BR are complementary prognostic factors in early stage breast cancer [J].

Ma, Xiao-Jun ;

Salunga, Ranelle ;

Dahiya, Sonika ;

Wang, Wilson ;

Carney, Erin ;

Durbecq, Virginie ;

Harris, Adrian ;

Goss, Paul ;

Sotiriou, Christos ;

Erlander, Mark ;

Sgroi, Dennis .

CLINICAL CANCER RESEARCH, 2008, 14 (09) :2601-2608

← 1 2 3 →